Epidemiology of invasive candidiasis;Epidémiologie des candidoses invasives

Revue Francophone des Laboratoires

Volumn 2013, Issue 450, 2013, Pages 27-36

  Toubas, Dominique ^a,b  

^a HÔPITAL MAISON BLANCHE   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Candidaemia; epidemiology; ICU; invasive candidiasis; risk factors

Indexed keywords

EID: 84875140449     PISSN: 1773035X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-035X(13)71944-0     Document Type: Article

References (55)

1. M.A. Pfaller, and D.J. Diekema International fungal surveillance participant group. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida Clin Microbiol Infect 10 Suppl1 2004 11 23 (Pubitemid 38386593)
2. M.A. Pfaller, and D.J. Diekema Epidemiology of invasive mycoses in North America Crit Rev Microbiol 36 2010 1 53
3. M.A. Pfaller, G.J. Moet, and S.A. Messer Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY. Antimicrobial surveillance program (2008 to 2009) J Clin Microbiol 49 2011 396 399
4. D.L. Horn, D. Neofytos, and E.J. Anaissie Epidemiology and outcomes of candidémie in 2019 patients: data from the prospective antifungal therapy alliance registry Clin Infect Dis 48 2009 1695 1703
5. A.M. Tortorano, C. Kibbler, and J. Peman Candidaemia in Europe: epidemiology and resistance Int J Antimicrob Agents 27 2006 359 366
6. M.A. Pfaller, R.N. Jones, and G.V. Doern International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents Diagn Microbiol Infect Dis 35 1999 19 25 (Pubitemid 29435937)
7. M.C. Arendrup, B. Bruun, and J.J. Christensen National surveillance of fungemia in Denmark (2004 to 2009) J Clin Microbiol 49 2011 325 334
8. O. Marchetti, J. Bille, and U. Fluckiger Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000 Clin Infect Dis 38 2004 311 320 (Pubitemid 38200105)
9. C.C. Kibbler, S. Seaton, and R.A. Barnes Management and outcome of bloodstream infections due to Candida species in England and Wales J Hosp Infect 54 2003 18 24 (Pubitemid 38002021)
10. H. Richet, P. Roux, and C. de Champs Candidemia in French hospitals: incidence rates and characteristics Clin Microbiol Infect 8 2002 405 412 (Pubitemid 34993817)
11. B. Sendid, A. Cotteau, and N. Francois Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links BMC Infect Dis 6 2006 80
12. C. Lass-Flörl The changing face of epidemiology of invasive fungal disease in Europe Mycoses 52 2009 97 205
13. M.C. Arendrup, K. Fuursted, and B. Gahrn-Hansen Semi-national surveillance of fungemia in Denmark 2004-2006: increasing incidence of fungemia and numbers of isolates with reduced azole susceptibility Clin Microbiol Infect 14 2008 487 494 (Pubitemid 351513938)
14. D. Diekema, S. Arbefeville, and L. Boyken The changing epidemiology of healthcare-associated candidemia over three decades Diagn Microbiol Infect Dis 73 2012 45 48
15. K. Lagrou, J. Verhaegen, and E. Peetermans Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species Eur J Clin Microbiol Infect Dis 26 2007 541 547 (Pubitemid 47106810)
16. M. Ortega, F. Marco, and A. Soriano Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008 J Hosp Infect 77 2011 157 161
17. J. Pemán, E. Cantón, and G. Quindós Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey J Antimicrob Chemother 67 2012 1181 1187
18. M.E. Bougnoux, G. Kac, and P. Aegerter Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome Intensive Care Med 34 2008 292 299 (Pubitemid 351207637)
19. M. Bassetti, L. Taramasso, and E. Nicco Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy PLoS One 6 2011 e24198
20. A.M. Tortorano, J. Peman, and H. Bernhardt Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study Eur J Clin Microbiol Infect Dis 23 2004 317 322 (Pubitemid 38669942)
21. H. Wisplinghoff, T. Bischoff, and S.M. Tallent Nosocomial bloodstream infections in US hospitals: analysis of 24179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 2004 309 317 (Pubitemid 39050477)
22. D.J. Diekema, S.A. Messer, and A.B. Brueggemann Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study J Clin Microbiol 40 2002 1298 1302 (Pubitemid 34279892)
23. R.A. Hajjeh, A.N. Sofair, and L.H. Harrison Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program J Clin Microbiol 42 2004 1519 1527 (Pubitemid 38500790)
24. A.L. Colombo, M. Nucci, and B.J. Park Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers J Clin Microbiol 44 2006 2816 2823 (Pubitemid 44228575)
25. Ahlquist A., Farley MM, Harrison LH, et al. Epidemiology of candidemia in metropolitan Atlanta and Baltimore City and County: preliminary results of population-based active, laboratory surveillance 2008-2009, 2009abstr. M-1241. Abstr 49th Intern Conf Antimicrob Agents Chemother.
26. M. Nucci, F. Queiroz-Telles, and A.M. Tobón Epidemiology of opportunistic fungal infections in Latin America Clin Infect Dis 51 2010 561 570
27. M.A. Pfaller, and D.J. Diekema Epidemiology of invasive candidiasis: a persistent public health problem Clin Microbiol Rev 20 2007 133 163 (Pubitemid 46167771)
28. M.C. Arendrup Epidemiology of invasive candidiasis Curr Opin Crit Care 16 2012 445 452
29. O. Eloy, V. Blanc, and P. Pina Epidémiologie des fongémies dans les hôpitaux français non universitaires en 2004: enquête multicentrique ColBVH Pathol Biol (Paris) 54 2006 523 530 (Pubitemid 44716611)
30. P. Honderlick, J. Gravisse, and P. Cahen Y a-t-il un changement perceptible dans l'écologie des candida species responsables de fungémie ? Observation de 2000 à 2006 à l'hôpital Foch Pathol Biol (Paris) 55 2007 531 533
31. B. Almirante, D. Rodriguez, and B.J. Park Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 J Clin Microbiol 43 2005 1829 1835
32. J.-P. Talarmin, D. Boutoille, and P. Tattevin Épidémiologie des candidémies: étude observationnelle prospective d'un an dans l'Ouest de la France Med Mal Infect 39 2009 877 885
33. A.C. Pasqualetto, W.L. Nedel, and T.S. Machado A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia J Hosp Infect 60 2005 129 134 (Pubitemid 40590580)
34. M.A. Pfaller, G.J. Moet, and S.A. Messer Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial surveillance program, 2008-2009 Antimicrob Agents Chemother 55 2011 561 566
35. M.C. Arendrup, S. Sulim, and A. Holm Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia J Clin Microbiol 49 2011 3300 3308
36. M.A. Pfaller, M. Castanheira, and S.A. Messer Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial surveillance program (2008-2009) Diagn Microbiol Infect Dis 68 2010 278 283
37. C.C. Blyth, S.C. Chen, and M.A. Slavin Not just little adults: Candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients Pediatrics 123 2009 1360 1368
38. D.H. Kett, E. Azoulay, and P.M. Echeverria Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study Crit Care Med 39 2011 665 670
39. M.A. Pfaller, S.A. Messer, and G.J. Moet Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial surveillance program (2008-2009) Int J Antimicrob Agents 38 2011 65 69
40. O. Lortholary, M. Desnos-Ollivier, and K. Sitbon Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2441 Patients Antimicrob Agents Chemother 55 2011 532 538
41. A. Paugam, M.T. Baixench, and F. Taieb Emergence de candidémies à Candida parapsilosis à l'hôpital Cochin. Caractérisation des isolats et recherche de facteurs de risque Pathol Biol (Paris) 59 2011 44 47
42. M. Bassetti, F. Ansaldi, and L. Nicolini Incidence of candidaemia and relationship with fluconazole use in an intensive care unit J Antimicrob Chemother 64 2009 625 629
43. C. Moran, C.A. Grussemeyer, and J.R. Spalding Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs Pediatr Infect Dis J 28 2009 433 435
44. M.A. Pfaller, D.J. Diekema, and D.L. Gibbs Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal surveillance program, 2001 to 2005 J Clin Microbiol 46 2008 842 849 (Pubitemid 351379967)
45. G. Garcia-Effron, E. Canton, and J. Pemán Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital J Antimicrob Chemother 2012 Aug 6
46. G. Thierry, F. Morio, and P. Le Pape Prevalence of Candida parapsilosis. C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test® Pathol Biol (Paris) 59 2011 52 56
47. M.A. Pfaller, D.J. Diekema, and D.L. Gibbs Candida krusei, a multidrug- resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal surveillance program, 2001 to 2005 J Clin Microbiol 46 2008 515 521 (Pubitemid 351231295)
48. P. Eggimann, J. Garbino, and D. Pittet Epidemiology of Candida species infections in critically ill non-immunosuppressed patients Lancet Infect Dis 3 2003 685 702 (Pubitemid 37345347)
49. M.J. Richards, J.R. Edwards, and D.H. Culver Nosocomial infections in medical intensive care units in the United States. National nosocomial infections surveillance system Crit Care Med 27 1999 887 892 (Pubitemid 29266004)
50. J.L. Vincent, J. Rello, and J. Marshall International study of the prevalence and outcomes of infection in intensive care units JAMA 302 2009 2323 2329
51. O. Leroy, J.P. Gangneux, and P. Montravers Epidemiology, management, and risk factors for death of invasive infections in critical care: a multicenter, prospective, observational study in France (2005-2006) Crit Care Med 37 2009 1612 1618
52. A. Holley, J. Dulhunty, and S. Blot Temporal trends, risk factors and outcomes in albicans and non albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units Int J Antimicrob Agents 33 2009 554 557
53. A.M. Tortorano, L. Caspani, and A.L. Rigoni Candidosis in the intensive care unit: a 20-year survey J Hosp Infect 57 2004 8 13 (Pubitemid 38594515)
54. D.J. Marriott, E.G. Playford, and S. Chen Determinants of mortality in non-neutropenic ICU patients with candidaemia Critical Care 13 2009 R115
55. I. Hassan, G. Powell, and M. Sidhu Excess mortality, length of stay and cost attributable to candidaemia J Infect 59 2009 360 365